Nuvalent

#药闻简讯# $Nuvalent(NUVL)$ 公布的 Alkove-1 关键阶段的 ORR 为 31%。这低于 1 期阶段公布的 38%

$Nuvalent(NUVL)$
Nuvalent therapeutics是一家临床阶段的生物技术公司。正在研发精准靶向疗法，旨在克服现有疗法在临床验证的激酶靶点治疗癌症患者方面的局限性。凭借在基于结构的设计方面的深厚专业知识，公司开发出具有卓越靶点选择性的创新小分子药物，以克服耐药性、减少不良事件，并推...

$Nuvalent(NUVL)$ 这是感觉这家也要被收购了么这估值我怎么就看不懂呢…

Nuvalent的ALK选择性抑制剂neladalkib（NVL-655）在ALKOVE-1 I/II期试验中，对ALK阳性非小细胞肺癌（NSCLC）患者显示出显著疗效，总客观缓解率（ORR）为31%-38%，中位缓解持续时间（DOR）长达9-14个月或未达，尤其在G1202R突变患者中ORR高达69%。试验涉及重度治疗患者，中位接受3线治疗，80%接受过...

$Royalty Pharma(RPRX)$ 和小分子达成2款合作。买权益。$Nuvalent(NUVL)$ 投资换分成。

$Nuvalent(NUVL)$ 8-K Current report, item 8.01 Accession Number: 0001193125-25-283893  Act: 34  Size: 195 KB 网页链接

$Nuvalent(NUVL)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-288263  Act: 33  Size: 1 MB 网页链接

$Nuvalent(NUVL)$ 144 Report of proposed sale of securities Accession Number: 0001193125-26-003150  Act: 33  Size: 9 KB 网页链接

$Nuvalent(NUVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-006576  Size: 19 KB 网页链接

$Nuvalent(NUVL)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-284602  Act: 33  Size: 923 KB 网页链接

$Nuvalent(NUVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-288313  Size: 12 KB 网页链接

$Nuvalent(NUVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-300638  Size: 16 KB 网页链接

$Nuvalent(NUVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-305343  Size: 10 KB 网页链接

$Nuvalent(NUVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-331014  Size: 6 KB 网页链接

$Nuvalent(NUVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193805-25-001648  Size: 30 KB 网页链接

$Nuvalent(NUVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-314301  Size: 6 KB 网页链接

$Nuvalent(NUVL)$ 144 Report of proposed sale of securities Accession Number: 0001193125-26-003154  Act: 33  Size: 9 KB 网页链接

$Nuvalent(NUVL)$ 144 Report of proposed sale of securities Accession Number: 0001193125-26-003156  Act: 33  Size: 7 KB 网页链接

$Nuvalent(NUVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-021122  Size: 14 KB 网页链接

$Nuvalent(NUVL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-288317  Size: 27 KB 网页链接